Viral Hepatitis
📧 Sign up to get email alerts when something new happens for Viral Hepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-12Clinical Trial Update: Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency [Phase 1, Phase 2]
This clinical trial update reports on the safety and efficacy outcomes of the Extracorporeal Liver Assist Device (ELAD) in patients with hep…
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating the efficacy and safety of the Extracorporeal Liver Assist Device (ELAD) in patients w…
-
FDA approval · 2013-04-02FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for EMTRIVA (emtricitabine) submitted by Gilead Sciences.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: HIV and Hepatitis Care Coordination in Methadone Treatment [NA]
A completed clinical trial evaluating HIV infection and viral hepatitis care coordination for individuals in methadone treatment; the update…
-
CLINICAL_TRIALS research · 2012-12-27Clinical Trial Update: NAT2 in Re-challenge of INH in Patients With Hepatitis [Phase 4]
Phase 4 clinical trial evaluating whether NAT2 genotype can guide re-challenge with isoniazid in patients with hepatitis during tuberculosis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-12-27Clinical Trial Update: Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment [Phase 4]
This document provides an update on regimens for reintroducing anti-tuberculosis therapy after hepatitis during TB treatment in a Phase 4 cl…
-
FDA approval · 2012-12-18FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company. The approval updates the labeling …
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Computer-Assisted Tailored Cue-card Health [CATCH] Study [Phase 1]
Phase 1 clinical trial update for the Computer-Assisted Tailored Cue-card Health (CATCH) study sponsored by RTI International; the trial in …
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects [Phase 1]
Phase 1 pharmacokinetic and safety study in healthy adults evaluating cabotegravir (GSK1265744) with rilpivirine and dolutegravir; study has…
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity
Completed clinical trial evaluating anti-tuberculosis drug levels and their correlation with drug-induced hepatotoxicity. The study aimed to…
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation [Phase 2]
A Phase 2 trial conducted by Conatus Pharmaceuticals evaluated the safety and efficacy of a caspase inhibitor (emricasan) in patients underg…
-
FDA approval · 2012-08-07FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Viread (tenofovir disoproxil fumarate) submitted by Gilead Sciences, Inc., resulting in chan…
-
FDA approval · 2012-08-07FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) submitted by Gilead Sciences, Inc. to update or expan…
-
EMA guidance · 2012-07-27World Hepatitis Day: 28 July 2012
EMA update highlighting World Hepatitis Day on 28 July 2012, focusing on awareness and public health messaging about hepatitis.
-
FDA approval · 2012-07-23FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Emtriva (emtricitabine) by Gilead Sciences.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals
A registry study evaluates the use of Xiyanping injectable traditional Chinese medicine across fifty hospitals for several viral and pediatr…
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study. [Phase 1]
This Phase 1 study assessed possible drug interactions between methadone and dolutegravir (GSK1349572) in individuals with HIV infection and…
-
EMA safety_alert · 2012-02-16European Medicines Agency informs doctors and patients about drug interaction between Victrelis and ritonavir-boosted HIV protease inhibitors
EMA informs about drug interaction between Victrelis (boceprevir) and ritonavir-boosted HIV protease inhibitors, advising clinicians and pat…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Long-term Effectiveness and Safety in Hepatitis-co-infected Patients
Abbott reports long-term effectiveness and safety data from a completed trial in patients co-infected with hepatitis and HIV. Results were p…
-
FDA approval · 2011-11-18FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company, potentially updating labeling or e…
-
FDA approval · 2011-11-18FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2011-11-16FDA Approved: RIBAVIRIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ribavirin from Aurobindo Pharma Limited, authorizing the generic ribavirin product.
-
FDA approval · 2011-09-29FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
The FDA approved a supplemental application for PEGASYS (peginterferon alfa-2a) submitted by pharmaand GmbH. The approval reflects an additi…
-
FDA approval · 2011-08-22FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
FDA approved a supplemental application for PEGASYS (peginterferon alfa-2a) submitted by pharmaand GmbH.
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: Treating Nonalcoholic Steatohepatitis (NASH) With Metformin [Phase 2]
A Phase 2 trial evaluating metformin for nonalcoholic steatohepatitis (NASH) was completed and results were posted.